Primary Multiple Skin Melanomas
Keywords:
maxillofacial region, inflammatory diseases, phlegmon
Abstract
Primary multiple skin melanomas represent a particular interest in modern oncology. Despite numerous studies on this topic in the global literature, most of them present isolated observations. The frequency of primary multiple melanomas in relation to all skin melanomas ranges from 0.54% to 4% according to various authors (American Cancer Society, 2021). In men, the risk of developing primary multiple melanoma is three times higher than in women, especially at a young age (Robert, C., Thomas, L., Bondarenko, I., ODay, S., Weber, J., Garbe, C., Lebbe, C., Baurain, J.F., Testori, A., Grob, J.J., Davidson, N., Richards, J., Maio, M., Hauschild, A., Miller, W.H.Jr., Gascon, P., Lotem, M., Harmankaya, K., Ibrahim, R., Francis, S., Chen, T.T., Humphrey, R., Hoos, A., Volchok, J.D., 2011).
References
1. Aceves, C., Anguiano, B., & Delgado, G. (2013). The extrathyronine actions of iodine as an antioxidant, apoptotic, and differentiation factor in various tissues. Thyroid, 23(8), 938-946. doi: 10.1089/thy.2012.0579.
2. Addor, F.A.S. (2018). Beyond photoaging: additional factors involved in the process of skin aging. Clinical Cosmet Investig Dermatol, 11, 437-443. doi: 10.2147/CCID.S177448.
3. Amaravadi, R., & Debnath, J. (2014). Mouse models address key concerns regarding autophagy inhibition in cancer therapy. Cancer Discovery, 4(8), 873-875.
4. American Cancer Society. (2021). Cancer Facts & Figures 2021. Retrieved from https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2021.html.
5. Banchereau, J., Palucka, A.K., Dhodapkar, M., Burkeholder, S., Taquet, N., Rolland, A., Taquet, S., Coquery, S., Wittkowski, K.M., & Bhardwaj, N. (2001). Immune and clinical responses in patients with metastatic melanoma to CD34+ progenitor-derived dendritic cell vaccine. Cancer Research, 61(17), 6451-6458.
6. Bandovkina, V.A., Kit, O.I., Frantsiyants, E.M., Sustretov, V.A., et al. (2018). Effect of estrogens on growth factors in melanoma and nevi. ASCO Annual Meeting J. Clin. Oncol., 36(Suppl.), abstract e21628.
7. Capatina, A.L., Lagos, D., & Brackenbury, W.J. (2020). Targeting Ion Channels for Cancer Treatment: Current Progress and Future Challenges. Reviews of Physiology, Biochemistry and Pharmacology, 1-43.
8. Denat, L., Kadekaro, A.L., Marrot, L., & Leachman, S.A. (2014). Melanocytes as instigators and victims of oxidative stress. Journal of Investigative Dermatology, 134(6), 1512-1518. doi: 10.1038/jid.2014.65.
9. Eells, J.T., Wong-Riley, M.T., & VerHoeve, J. (2004). Mitochondrial signal transduction in accelerated wound and retinal healing by near-infrared light therapy. Mitochondrion, 4(5-6), 559-567.
10. El-Safadi, S., Estel, R., Mayser, P., & Muenstedt, K. (2014). Primary malignant melanoma of the urethra: a systematic analysis of the current literature. Archives of Gynecology and Obstetrics, 289(5), 935-943. doi: 10.1007/s00404-013-3130-3.
11. Pesapane, F., et al. (2020). Imaging diagnosis of metastatic breast cancer. Insights into Imaging, 11(1), 1-14.
12. Robert, C., Thomas, L., Bondarenko, I., ODay, S., Weber, J., Garbe, C., Lebbe, C., Baurain, J.F., Testori, A., Grob, J.J., Davidson, N., Richards, J., Maio, M., Hauschild, A., Miller, W.H.Jr., Gascon, P., Lotem, M., Harmankaya, K., Ibrahim, R., Francis, S., Chen, T.T., Humphrey, R., Hoos, A., Volchok, J.D. (2011). Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. New England Journal of Medicine, 364(26), 2517-2526. doi: 10.1056/NEJMoa1104621.
13. Shavkatovna, S.S., & Rakhimov, N.M. (2021). Morphological Verification Of Malignant Neoplasm Of The Urinary System With Multiple Bone Metastases. The American Journal of Medical Sciences and Pharmaceutical Research, 3(06), 145-149.
14. Shaxanova, Sh.S., Raximov, N.M. (2022). Improving the combined treatment tactics of many osteogen metastases of malignant tumors of the urinary-body system. Web of Scientist: International Scientific Research Journal, 4/30, 1145-1149.
15. Gridneva Ya.V. Urethral melanoma. Cancer urology 2005;1(3):66-70. [Gridneva Ya.V. Urethral melanoma. Cancer Urology 2005;1(3):66-70. (In Russ.)].
16. Malignant neoplasms in Russia in 2019 (incidence and mortality).
17. Clinical guidelines. Skin melanoma and mucous membrane melanoma. / Russian Society of Clinical Oncologists // 2021.
18. Rakhimov N.M., Shahanova Sh.Sh., Khakimov A.A., Kalyuta T.Yu., Velikanova M.G., Korolev A.Yu. Effectiveness of radiation therapy in patients with bone metastases of prostate cancer and renal cell carcinoma. 2022/9/7. Journal of Biomedicine and Practice. Volume 7, Issue 4.
19. Shahanova Sh.Sh., Rakhimov N.M. Multimodal approach to the treatment of multiple osteogenic metastases of kidney and prostate cancer. Clinical and Experimental Oncology 2020, No. 4, Pp. 50-56.
20. Shahanova Sh.Sh., Rakhimov N.M., Koraboev F.T. Increasing the effectiveness of targeted therapy in the treatment of kidney and prostate cancer with osteogenic metastases. Journal of Reproductive Health and Uro-Nephrological Research 2022/6/27, Volume 3, Issue 2.
2. Addor, F.A.S. (2018). Beyond photoaging: additional factors involved in the process of skin aging. Clinical Cosmet Investig Dermatol, 11, 437-443. doi: 10.2147/CCID.S177448.
3. Amaravadi, R., & Debnath, J. (2014). Mouse models address key concerns regarding autophagy inhibition in cancer therapy. Cancer Discovery, 4(8), 873-875.
4. American Cancer Society. (2021). Cancer Facts & Figures 2021. Retrieved from https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2021.html.
5. Banchereau, J., Palucka, A.K., Dhodapkar, M., Burkeholder, S., Taquet, N., Rolland, A., Taquet, S., Coquery, S., Wittkowski, K.M., & Bhardwaj, N. (2001). Immune and clinical responses in patients with metastatic melanoma to CD34+ progenitor-derived dendritic cell vaccine. Cancer Research, 61(17), 6451-6458.
6. Bandovkina, V.A., Kit, O.I., Frantsiyants, E.M., Sustretov, V.A., et al. (2018). Effect of estrogens on growth factors in melanoma and nevi. ASCO Annual Meeting J. Clin. Oncol., 36(Suppl.), abstract e21628.
7. Capatina, A.L., Lagos, D., & Brackenbury, W.J. (2020). Targeting Ion Channels for Cancer Treatment: Current Progress and Future Challenges. Reviews of Physiology, Biochemistry and Pharmacology, 1-43.
8. Denat, L., Kadekaro, A.L., Marrot, L., & Leachman, S.A. (2014). Melanocytes as instigators and victims of oxidative stress. Journal of Investigative Dermatology, 134(6), 1512-1518. doi: 10.1038/jid.2014.65.
9. Eells, J.T., Wong-Riley, M.T., & VerHoeve, J. (2004). Mitochondrial signal transduction in accelerated wound and retinal healing by near-infrared light therapy. Mitochondrion, 4(5-6), 559-567.
10. El-Safadi, S., Estel, R., Mayser, P., & Muenstedt, K. (2014). Primary malignant melanoma of the urethra: a systematic analysis of the current literature. Archives of Gynecology and Obstetrics, 289(5), 935-943. doi: 10.1007/s00404-013-3130-3.
11. Pesapane, F., et al. (2020). Imaging diagnosis of metastatic breast cancer. Insights into Imaging, 11(1), 1-14.
12. Robert, C., Thomas, L., Bondarenko, I., ODay, S., Weber, J., Garbe, C., Lebbe, C., Baurain, J.F., Testori, A., Grob, J.J., Davidson, N., Richards, J., Maio, M., Hauschild, A., Miller, W.H.Jr., Gascon, P., Lotem, M., Harmankaya, K., Ibrahim, R., Francis, S., Chen, T.T., Humphrey, R., Hoos, A., Volchok, J.D. (2011). Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. New England Journal of Medicine, 364(26), 2517-2526. doi: 10.1056/NEJMoa1104621.
13. Shavkatovna, S.S., & Rakhimov, N.M. (2021). Morphological Verification Of Malignant Neoplasm Of The Urinary System With Multiple Bone Metastases. The American Journal of Medical Sciences and Pharmaceutical Research, 3(06), 145-149.
14. Shaxanova, Sh.S., Raximov, N.M. (2022). Improving the combined treatment tactics of many osteogen metastases of malignant tumors of the urinary-body system. Web of Scientist: International Scientific Research Journal, 4/30, 1145-1149.
15. Gridneva Ya.V. Urethral melanoma. Cancer urology 2005;1(3):66-70. [Gridneva Ya.V. Urethral melanoma. Cancer Urology 2005;1(3):66-70. (In Russ.)].
16. Malignant neoplasms in Russia in 2019 (incidence and mortality).
17. Clinical guidelines. Skin melanoma and mucous membrane melanoma. / Russian Society of Clinical Oncologists // 2021.
18. Rakhimov N.M., Shahanova Sh.Sh., Khakimov A.A., Kalyuta T.Yu., Velikanova M.G., Korolev A.Yu. Effectiveness of radiation therapy in patients with bone metastases of prostate cancer and renal cell carcinoma. 2022/9/7. Journal of Biomedicine and Practice. Volume 7, Issue 4.
19. Shahanova Sh.Sh., Rakhimov N.M. Multimodal approach to the treatment of multiple osteogenic metastases of kidney and prostate cancer. Clinical and Experimental Oncology 2020, No. 4, Pp. 50-56.
20. Shahanova Sh.Sh., Rakhimov N.M., Koraboev F.T. Increasing the effectiveness of targeted therapy in the treatment of kidney and prostate cancer with osteogenic metastases. Journal of Reproductive Health and Uro-Nephrological Research 2022/6/27, Volume 3, Issue 2.
Published
2023-05-14
How to Cite
Rakhimov Nodir Makhammatkulovich, 2. Shahanova Shakhnoza Shavkatovna, 3. Murodov Shakhzod Tokhir ugli, Pulatov Ozod Abdugofurovich, Allazov Firuz Niyazovich, & Madalimov Axror Alievich. (2023). Primary Multiple Skin Melanomas. Central Asian Journal of Medical and Natural Science, 4(3), 392-399. https://doi.org/10.17605/cajmns.v4i3.1536
Issue
Section
Articles
